Aridis Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.156; its P/E ratio is -0.40; Aridis Pharmaceuticals is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 417.00K	$ 19.65M	$ 1.08M	$ 1.21M	$ 399.00K
Gross Profit	$ 417.00K	$ 19.65M	$ 1.08M	$ 1.21M	$ 399.00K
EBIT	$ -842.00K	$ 13.70M	$ 6.67M	$ -7.39M	$ -7.39M
EBITDA	$ -783.00K	$ 13.76M	$ 6.75M	$ -7.88M	$ -7.26M
Net Income Common Stockholders	$ -83.00K	$ 12.14M	$ 6.06M	$ -6.39M	$ -8.24M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 35.00K	$ 19.00K	$ 1.32M	$ 5.06M	$ 2.63M
Total Assets	$ 6.53M	$ 6.48M	$ 9.43M	$ 14.70M	$ 12.12M
Total Debt	$ 4.84M	$ 6.29M	$ 1.91M	$ 6.13M	$ 14.08M
Net Debt	$ 4.80M	$ 6.28M	$ 586.00K	$ 1.07M	$ 11.45M
Total Liabilities	$ 18.34M	$ 21.40M	$ 37.32M	$ 38.93M	$ 47.94M
Stockholders Equity	$ -11.80M	$ -14.94M	$ -27.88M	$ -24.23M	$ -35.82M
Cash Flow	-
Free Cash Flow	$ -983.00K	$ -4.33M	$ -4.00M	$ -8.61M	$ -4.26M
Operating Cash Flow	$ -983.00K	$ -4.34M	$ -4.00M	$ -8.56M	$ -4.26M
Investing Cash Flow	-	$ 14.00K	-	$ -49.00K	-
Financing Cash Flow	$ 999.00K	$ 3.03M	$ 263.00K	$ 11.03M	$ -554.00K

Currency in USD

Aridis Pharmaceuticals Earnings and Revenue History

Income Statement >

Aridis Pharmaceuticals Debt to Assets

Balance Sheet >

Aridis Pharmaceuticals Cash Flow

Cash Flow >

Aridis Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing